Research use · informational overview

RuskiPeptidi .com

GHRP-6

5 mg / Lyophilized powder / ≥ 98 %

A hexapeptide ghrelin receptor agonist from the early generation of GH secretagogues.

Documentation

The description states the methods and declared data. Verify the COA, chromatogram and MS confirmation for the specific batch at the source.

What to check
Catalog
RP-GHR-05
Purity
≥ 98 %
Analysis
HPLC + MS
Updated
3 November 2026
Unlabelled vial with white powder on dark green slate next to a laboratory spatula.
RUO / research use ≥ 98 %

Illustrative image generated with artificial intelligence. It does not show actual product packaging.

What is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide from the family of GH secretagogues. It was developed in the course of research on growth hormone release and is one of the earlier peptides in this group to have been studied extensively in animals and in smaller human studies.

It acts as an agonist of the GHS-R1a receptor, to which natural ghrelin also binds. Its effects are therefore not limited to the pituitary — receptors are also present in other tissues, including those that regulate appetite.

What has been researched?

In research, GHRP-6 has been linked to:

  • increased growth hormone secretion;
  • increased hunger and food intake;
  • effects on prolactin and cortisol at higher doses;
  • changes in body composition in some models.

The effect on appetite in particular is often overlooked but important: if a study examines body mass, food intake must also be controlled. Differences between groups may be the result of behaviour, not only of pharmacology.

The difference between GHRP-6 and newer peptides

Newer GH secretagogues such as Ipamorelin were designed with greater selectivity in mind. This means that in certain models they stimulate growth hormone secretion without influencing appetite or other hormones to the same degree. GHRP-6 is therefore often used as a reference compound in comparative studies.

“Newer” does not automatically mean “safer”. It means a different mechanism profile and, often, less long-term data.

Safety

GHRP-6 is not an approved medicine. Data on long-term safety in humans are limited, and possible adverse effects include those associated with increased growth hormone secretion and appetite. In competitive sport, GH secretagogues may be prohibited; check the WADA list.

Particular caution is required in people with endocrine or metabolic conditions — but that is already a clinical domain, not a research one.

Quality and documentation

The listing declares a purity of ≥ 98 % (HPLC) and confirmed identity. For research reproducibility it matters that the vial is linked to a batch number and an analytical report. More on what to check is in the guide to the certificate of analysis.

Storage

Store the lyophilizate at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and follow the laboratory protocol. Avoid repeated freezing.

Conclusion

GHRP-6 is a classic GH secretagogue with a well-documented pharmacological profile, but without approved-medicine status. Its research value lies mainly in comparison with more selective compounds.

Frequently asked questions

Why does GHRP-6 increase appetite?
GHRP-6 acts on the ghrelin receptor, which is also involved in the regulation of hunger. In studies, participants often reported increased hunger, which must be taken into account when designing studies.
Is GHRP-6 better than Ipamorelin?
They are not interchangeable. They differ in selectivity and mechanism profile. “Better” depends on the research question, not on market opinion.
Does GHRP-6 affect other hormones?
At higher doses, studies have reported effects on prolactin and cortisol. Monitoring several hormonal markers is therefore important when designing experiments.

Sources and further reading

Related peptides

Often compared.

Full catalog
Unlabelled vial on brushed stainless steel with a geometric shadow and glass capillary. Growth hormone ≥ 99 %
RP-IPA-05 5 mg

Ipamorelin

A pentapeptide that in research stimulates growth hormone secretion with relatively high selectivity.

Research use

Lyophilized powder · 5 mg

Details
Two unlabelled glass vials on a matte glass shelf with slight condensation. Growth hormone ≥ 98 %
RP-CJC-02 2 mg

CJC-1295

A modified GHRH(1–29) without albumin binding, therefore shorter-acting than the version with DAC.

Research use

Lyophilized powder · 2 mg

Details

Context

Read before you experiment.

All articles
A precision laboratory balance and two unlabelled vials on brushed steel. Hormones
3 min read

Ipamorelin and CJC-1295: GH secretagogues

How GH secretagogues work, how Ipamorelin, CJC-1295 without DAC and GHRP-6 differ, and what studies show about growth hormone.

Read article
A translucent glass sphere and a polished steel ring with a geometric shadow on warm stone. Basics
3 min read

Peptides and steroids: key differences

Peptides and steroids differ in structure, mechanism, regulation and risks. An explanation of why they should not be equated and where misconceptions arise.

Read article
A stack of blank laboratory documents with an attached paper strip and a magnifying glass. Quality
4 min read

How to read a certificate of analysis (COA)

A practical guide through a peptide certificate of analysis: what information it must contain, what purity, identity and batch mean, and what the signs of a poor COA are.

Read article
An hourglass, a sealed blank folder and two unlabelled vials on dark green slate. Legal framework
4 min read

Peptides and WADA: what is prohibited in sport

An overview of the status of peptides on the WADA list: which groups are prohibited, why the list is not the same as a list of medicines, and how to check a specific compound.

Read article

Explore further

GHRP-6: specification and limitations

The catalog collects specifications, described methods and related research. All described materials are intended for laboratory use.